Back To Index  <<  Back To Templates

ref Template  BC LabeledDrug

Id 2.16.840.1.113883.3.1937.777.17.10.10 Effective Date valid from 2017‑03‑31 02:01:57
Status draft Draft Version Label
Name BCLabeledDrug Display Name BC LabeledDrug
Description
Used to add the following extensions to Labeled Drug:

  Drug Description: The Drug Description (LabeledDrug/e2e:desc)has been added to the schema to support a free form textual description of the drug. This is usually only populated for custom compounds, providing instructions on the composition and creation of the compound.
  •   Drug Form: The Drug Form (LabeledDrug/e2e:formCode) has been added to the schema communicate the administration form of the drug (e.g. tablet, capsule, powder, etc.).

  •   Drug Ingredient: Frequently the drug strength is assumed to be included in or implied by the drug code itself. For example, there is a specific DIN code for TYLENOL 325 mg tablet (00723894). However, the specification supports the communication of the drug strength attribute as a separate element to accommodate historical or patient reported data that may not be coded or may not have the strength pre-coordinated in the drug code or implied through the drug name. 

Classification CDA Entry Level Template
Open/Closed Open (other than defined elements are allowed)
Used by / Uses
Used by 13 templates, Uses 0 templates
Used by Template id as Name Version
2.16.840.1.113883.3.1818.10.4.16 draft BC Medication Identification 2017‑03‑30 23:55:59
2.16.840.1.113883.3.1818.10.3.18 link draft BC Medication Event 2017‑04‑03 02:55:58
2.16.840.1.113883.3.1818.10.2.19.1 link draft BC CDA E2E Medication List with Entries 2017‑04‑03 06:34:17
2.16.840.1.113883.3.1818.10.1.1 link draft BC CDA E2E EMR Conversion 2016‑11‑18 18:04:46
2.16.840.1.113883.3.1818.10.1.2 link draft BC CDA E2E Generic Episodic Document 2017‑04‑04 13:48:26
2.16.840.1.113883.3.1818.10.1.2 link draft BC CDA E2E Generic Episodic Document 2017‑04‑04 13:39:16
2.16.840.1.113883.3.1818.10.1.3 link draft BC CDA E2E Patient Chart Transfer 2017‑04‑04 12:36:54
2.16.840.1.113883.3.1818.10.2.9.1 link draft BC CDA E2E Current Medications with Entries 2017‑04‑03 05:41:18
2.16.840.1.113883.3.1818.10.1.6 link draft BC CDA E2E Structured Referral 2017‑04‑04 15:16:39
2.16.840.1.113883.3.1818.10.1.7 link draft BC CDA E2E Structured Consult Report 2017‑04‑04 13:59:01
2.16.840.1.113883.3.1818.10.4.20 link draft BC Medication Prescription Event 2017‑04‑01 07:08:11
2.16.840.1.113883.3.1818.10.4.7 link draft BC Medication Dispense Event 2017‑04‑01 05:33:20
2.16.840.1.113883.3.1818.10.4.8 link draft BC Dose Observation 2017‑03‑31 00:24:47
Relationship Adaptation: template 2.16.840.1.113883.10.12.310 (2005‑09‑07)
Item DT Card Conf Description Label
hl7:manufacturedLabeledDrug
1 … 1 R CONF‑1555
treetree @classCode
cs 1 … 1 F MMAT CONF‑1556
treetree @determinerCode
cs 1 … 1 F KIND CONF‑1557
treetree hl7:code
CE CWE 1 … 1 R CONF‑1558
  Constraint
  1. SHALL be selected from ValueSet ClinicalDrug 2.16.840.1.113883.2.20.3.29 DYNAMIC [CONF:1558]. 

treetree hl7:name
EN 1 … 1 R CONF‑1559
treetree e2e:desc
ED 0 … 1 CONF‑1560
treetree e2e:formCode
CD CWE 0 … 1 CONF‑1561
treetree e2e:ingredient
0 … 50 CONF‑4325
treeblank treetree @classCode
cs 1 … 1 F INGR CONF‑4326
treeblank treetree e2e:quantity
PQ 0 … 1 R CONF‑4327
treeblank treetree e2e:ingredient
1 … 1 R CONF‑4328
treeblank treeblank treetree @classCode
cs 1 … 1 F MMAT CONF‑4329
treeblank treeblank treetree @determinerCode
cs 1 … 1 F KIND CONF‑4330
treeblank treeblank treetree e2e:code
CD 0 … 1 CONF‑4331
  Constraint

SHALL be selected from ValueSet ClinicalDrug 2.16.840.1.113883.2.20.3.29 DYNAMIC (CDA R2 Extension) [CONF:4331]. 

treeblank treeblank treetree e2e:name
ED 0 … 1 CONF‑4332